MBRS-56. SYSTEMATIC DRUG REPURPOSING IDENTIFIES DIGOXIN AS A DRUG THAT PROLONGS SURVIVAL IN PDOX MODELS OF GROUPS 3 AND 4 MEDULLOBLASTOMA AT CLINICALLY RELEVANT DOSES
MBRS-56. 系统性药物再利用研究发现，在临床相关剂量下，地高辛可延长第 3 组和第 4 组髓母细胞瘤 PDOX 模型中的生存期。
期刊:Aging Cell
影响因子:7.1
doi:10.1111/acel.12924
Theurey, Pierre; Connolly, Niamh M C; Fortunati, Ilaria; Basso, Emy; Lauwen, Susette; Ferrante, Camilla; Moreira Pinho, Catarina; Joselin, Alvin; Gioran, Anna; Bano, Daniele; Park, David S; Ankarcrona, Maria; Pizzo, Paola; Prehn, Jochen H M; Injac, Sarah; Huang, Lei; Zhao, Hong; Lin, Qi; Kogiso, Mari; Man, Chris; Li, Xiao-nan; Wong, Stephen; Lau, Ching
